Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension
- 4 March 1999
- journal article
- clinical trial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 340 (9), 677-684
- https://doi.org/10.1056/nejm199903043400902
Abstract
Recent reports suggest that calcium-channel blockers may be harmful in patients with diabetes and hypertension. We previously reported that antihypertensive treatment with the calcium-channel blocker nitrendipine reduced the risk of cardiovascular events. In this post hoc analysis, we compared the outcome of treatment with nitrendipine in diabetic and nondiabetic patients.Keywords
This publication has 24 references indexed in Scilit:
- Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly.Archives of Internal Medicine, 1998
- Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDMDiabetes Care, 1998
- Treatment of hypertensive patients with diabetesThe Lancet, 1998
- The Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Patients with Non-Insulin-Dependent Diabetes and HypertensionThe New England Journal of Medicine, 1998
- Diabetes and Risk of Adverse Events With Calcium AntagonistsDiabetes Care, 1998
- Calcium antagonists and cardiovascular events in patients with hypertension and diabetesThe Lancet, 1998
- Isradipine, raised glycosylated haemoglobin, and risk of cardiovascular eventsThe Lancet, 1997
- Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertensionThe Lancet, 1997
- NifedipineCirculation, 1995
- Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention TrialDiabetes Care, 1993